Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1080/10428194.2021.1964026 http://scihub22266oqcxt.onion/10.1080/10428194.2021.1964026 34387145!ä!34387145 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Leuk+Lymphoma 2021 ; 62 (14): 3516-3520 Nephropedia Template TP {{tp|p=34387145|t=2021. Acute leukemia and SARS-CoV-2 infection: clinical characteristics and risk factors for mortality |pdf=|usr=}}{{34387145}} gab.com Text Acute leukemia and SARS-CoV-2 infection: clinical characteristics and risk factors for mortality JO: Leuk Lymphoma http://www.kidney.de/pget.php?&tw=1&pmid=34387145 #FOAvip Patients with acute leukemia (AL) have a high mortality rate from coronavirus disease 2019 (COVID-19). However, studies including patients with AL and COVID-19 are few. Fifty-one patients with AL and COVID-19 were included in our study. The mortality rate was 17/51 (29.4%). In all cases, death was associated with COVID-19 pneumonia. The major driver of outcome was the disease status (worse outcome was observed in newly diagnosed (OR, 6.00; 95% CI, 1.133 - 15.188) and patients with bone marrow aplasia (OR 4.148 [95% CI 1.133 - 15.188])). Higher mortality rate was associated with lower platelet count, prolonged PT, higher ISTH DIC score, CRP and LDH. Moreover, careful risk-benefit assessment regarding the continuation of anticancer therapy is required in patients receiving nonintensive and supportive therapy. Considering the high frequency of intrahospital viral transmission (50.98%), isolation of AL patients in single rooms, and permanent symptom monitoring and testing should be prioritized. Twit Text FOAVip Acute leukemia and SARS-CoV-2 infection: clinical characteristics and risk factors for mortality ????Leuk Lymphoma http://www.kidney.de/pget.php?&tw=1&pmid=34387145 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34387145 #FOAvip English Wikipedia <ref>{{Cite pmid|34387145}}</ref> Acute leukemia and SARS-CoV-2 infection: clinical characteristics and risk factors for mortality #MMPMID34387145 Mitrovic M; Pantic N; Sabljic N; Vucic M; Bukumiric Z; Virijevic M; Pravdic Z; Rajic J; Todorovic-Balint M; Vidovic A; Suvajdzic-Vukovic N Leuk Lymphoma 2021[Dec]; 62 (14): 3516-3520 PMID34387145show ga Patients with acute leukemia (AL) have a high mortality rate from coronavirus disease 2019 (COVID-19). However, studies including patients with AL and COVID-19 are few. Fifty-one patients with AL and COVID-19 were included in our study. The mortality rate was 17/51 (29.4%). In all cases, death was associated with COVID-19 pneumonia. The major driver of outcome was the disease status (worse outcome was observed in newly diagnosed (OR, 6.00; 95% CI, 1.133 - 15.188) and patients with bone marrow aplasia (OR 4.148 [95% CI 1.133 - 15.188])). Higher mortality rate was associated with lower platelet count, prolonged PT, higher ISTH DIC score, CRP and LDH. Moreover, careful risk-benefit assessment regarding the continuation of anticancer therapy is required in patients receiving nonintensive and supportive therapy. Considering the high frequency of intrahospital viral transmission (50.98%), isolation of AL patients in single rooms, and permanent symptom monitoring and testing should be prioritized. |*COVID-19[MESH] |*Leukemia/diagnosis/epidemiology/therapy[MESH] |Humans[MESH] |Risk Factors[MESH]Acute leukemia and SARS-CoV-2 infection: clinical characteristics and (epmc).pdf DeepDyve Pubget Overpricing